Literature DB >> 24422127

Odanacatib, a cathepsin K inhibitor, superior to alendronate.

.   

Abstract

Entities:  

Year:  2013        PMID： 24422127      PMCID： PMC3789222          DOI： 10.1038/bonekey.2013.160

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN： 2047-6396


× No keyword cloud information.
  3 in total

1.  Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: a head-to-head comparison with alendronate.

Authors:  Donald S Williams; Paul J McCracken; Mona Purcell; Maureen Pickarski; Parker D Mathers; Alan T Savitz; John Szumiloski; Richa Y Jayakar; Sangeetha Somayajula; Stephen Krause; Keenan Brown; Christopher T Winkelmann; Boyd B Scott; Lynn Cook; Sherri L Motzel; Richard Hargreaves; Jeffrey L Evelhoch; Antonio Cabal; Bernard J Dardzinski; Thomas N Hangartner; Le T Duong
Journal:  Bone       Date:  2013-06-24       Impact factor: 4.398

2.  High-resolution peripheral quantitative computed tomography and finite element analysis of bone strength at the distal radius in ovariectomized adult rhesus monkey demonstrate efficacy of odanacatib and differentiation from alendronate.

Authors:  Antonio Cabal; Richa Y Jayakar; Swanand Sardesai; Eual A Phillips; John Szumiloski; Diane J Posavec; Parker D Mathers; Alan T Savitz; Boyd B Scott; Christopher T Winkelmann; Sherri Motzel; Lynn Cook; Richard Hargreaves; Jeffrey L Evelhoch; Bernard J Dardzinski; Thomas N Hangartner; Paul J McCracken; Le T Duong; Donald S Williams
Journal:  Bone       Date:  2013-06-20       Impact factor: 4.398

3.  Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial.

Authors:  Kim Brixen; Roland Chapurlat; Angela M Cheung; Tony M Keaveny; Thomas Fuerst; Klaus Engelke; Robert Recker; Bernard Dardzinski; Nadia Verbruggen; Shabana Ather; Elizabeth Rosenberg; Anne E de Papp
Journal:  J Clin Endocrinol Metab       Date:  2013-01-21       Impact factor: 5.958
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.